<div id="readability-page-1"><p>Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) rose 4.5% on Friday . The stock traded as high as $16.96 and last traded at $16.79. Approximately 84,455 shares were traded  during trading, a decline of 91% from the average daily volume of 941,152 shares. The stock had previously closed at $16.06.</p><h2>Analyst Ratings Changes</h2><p>A number of brokerages recently weighed in on OMDA. Weiss Ratings  restated a &#34;sell (d)&#34; rating on shares of Omada Health in a report on Wednesday, October 8th. The Goldman Sachs Group  restated a &#34;buy&#34; rating and issued a $26.00 target price on shares of Omada Health in a report on Friday, January 16th. Evercore ISI upped their target price on Omada Health from $27.00 to $28.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, November 7th. Morgan Stanley  set a $32.00 price target on Omada Health in a research note on Thursday, December 18th. Finally, BMO Capital Markets assumed coverage on shares of Omada Health in a research report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $27.00 target price on the stock. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one  has assigned  a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $25.10.</p><p><b>Read Our Latest Stock Report on Omada Health</b></p><h2>Omada Health Price Performance</h2><p>The stock has a market capitalization of $957.25 million and a price-to-earnings ratio of -66.12. The stock's 50 day simple moving average is $16.45 and its 200-day simple moving average is $19.89. </p><h2>Insider Activity at Omada Health</h2><p>In other news, CEO Sean P. Duffy sold 40,796 shares of the business's stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the sale, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $2,019,971.80. The trade was a 24.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, President Wei-Li Shao sold 5,618 shares of the firm's stock in a transaction on Monday, December 29th. The shares were sold at an average price of $16.13, for a total transaction of $90,618.34. Following the completion of the transaction, the president owned 69,079 shares in the company, valued at $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 276,893 shares of company stock valued at $4,336,787. </p><h2>Institutional Inflows and Outflows</h2><p>Large investors have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in  Omada Health during the 2nd quarter valued at $32,000.  Strs Ohio bought a new position in shares of  Omada Health during the 3rd quarter worth about $38,000.  Rakuten Investment Management Inc. acquired a new position in shares of  Omada Health during the third quarter valued at about $49,000.  JPMorgan Chase &amp; Co. bought a new stake in shares of  Omada Health in the third quarter valued at about $82,000.  Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in  Omada Health during the third quarter worth about $95,000. </p><h2>Omada Health Company Profile</h2> (Get Free Report)<p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.  </p><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p><h2>See Also</h2><ul><li>Five stocks we like better than Omada Health</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Do not delete, read immediately</li><li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li><li>The $100 Trillion AI Story No One Is Telling You</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Omada Health Right Now?</h2><p>Before you consider Omada Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OMDA

<p>Omada Health (NASDAQ:OMDA) shares rose 4.5% to $16.79, with a trading volume significantly lower than average. Analyst ratings show a consensus of "Moderate Buy" with a target price of $25.10. Recent insider sales included CEO Sean P. Duffy selling 40,796 shares. The company specializes in digital health solutions for chronic conditions, combining data analytics and coaching. Institutional investors have also increased their stakes in the company.</p>

Omada Health (NASDAQ:OMDA) Stock Price Up 4.5% - Should You Buy?